COMBINATION RADIOTHERAPY AND CHEMOTHERAPY IN MURINE BLADDER-CANCER

被引：18

作者：

WELDON, TE ^{[1
]}

KURSH, E ^{[1
]}

NOVAK, LJ ^{[1
]}

PERSKY, L ^{[1
]}

机构：

[1] CASE WESTERN RESERVE UNIV,DIV UROL,CLEVELAND,OH 44106

来源：

UROLOGY | 1979年 / 14卷 / 01期

关键词：

D O I：

10.1016/0090-4295(79)90212-7

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

A murine transitional cell carcinoma tumor model has been used to evaluate the combined use of radiotherapy and three chemotherapeutic agents, doxorubicin hydrochloride (Adriamycin), cyclophosphamide, and cis-diamminedichloroplatinum. The preliminary radiation therapy evaluation demonstrated that the tumor is radiosensitive. The combined use of cyclophosphamide and radiation therapy was the most effective regimen, especially when the drug was started prior to radiotherapy. Cis-diamminedichloroplatinum and radiation were a lethal combination, but a synergistic effect was produced when the drug was given after completion of radiotherapy. Doxorubicin hydrochloride and radiotherapy may be synergistic, but more evaluation is necessary. © 1979.

引用

页码：47 / 52

页数：6

共 28 条

[1] COMBINATION THERAPY WITH DRUGS AND RADIATION [J].

BLEEHEN, NM .

BRITISH MEDICAL BULLETIN, 1973, 29 (01) :54-58

[2]

BYFIELD JE, 1974, CANCER CHEMOTH REP 1, V58, P527

[3]

CARTER SK, 1975, CANCER-AM CANCER SOC, V36, P729, DOI 10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO

[4]

2-D

[5]

CASSADY JR, 1975, CANCER, V36, P946, DOI 10.1002/1097-0142(197509)36:3<946::AID-CNCR2820360316>3.0.CO

[6]

2-5

[7]

DeKernion J B, 1974, Urology, V4, P63, DOI 10.1016/0090-4295(74)90110-1

[8] CYSTECTOMY AFTER RADIOTHERAPEUTIC ABLATION OF INVASIVE TRANSITIONAL CELL-CANCER [J].

DEWEERD, JH ;

COLBY, MY ;

MYERS, RP ;

CUPPS, RE .

JOURNAL OF UROLOGY, 1977, 118 (02) :260-261

[9]

DIMARCO A, 1975, ADRIAMYCIN CANCER 1, V59, P91

[10]

FOX MILES, 1965, BRIT J UROL, V37, P399, DOI 10.1111/j.1464-410X.1965.tb09616.x

← 1 2 3 →